dactinomycin has been researched along with Sertoli Cell Tumor in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Slayton, RE | 1 |
| Reddick, RL; Walton, LA | 1 |
| Cangir, A; Smith, J; van Eys, J | 1 |
1 review(s) available for dactinomycin and Sertoli Cell Tumor
| Article | Year |
|---|---|
Management of germ cell and stromal tumors of the ovary.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Choriocarcinoma; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Dysgerminoma; Female; Granulosa Cell Tumor; Humans; Leydig Cell Tumor; Mesonephroma; Middle Aged; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Pregnancy; Sertoli Cell Tumor; Teratoma; Thecoma; Vincristine | 1984 |
2 other study(ies) available for dactinomycin and Sertoli Cell Tumor
| Article | Year |
|---|---|
Sertoli-Leydig cell tumor of the ovary with teratomatous differentiation: clinicopathologic considerations.
Topics: Adult; Cyclophosphamide; Dactinomycin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Leydig Cell Tumor; Ovarian Neoplasms; Sertoli Cell Tumor | 1982 |
Improved prognosis in children with ovarian cancers following modified VAC (vincristine sulfate, dactinomycin, and cyclophosphamide) chemotherapy.
Topics: Adolescent; Antineoplastic Agents; Child; Cyclophosphamide; Dactinomycin; Drug Therapy, Combination; Dysgerminoma; Female; Humans; Leydig Cell Tumor; Ovarian Neoplasms; Prognosis; Remission, Spontaneous; Sertoli Cell Tumor; Teratoma; Time Factors; Vincristine | 1978 |